A San Diego man with a rare form of cancer was recently treated at Scripps MD Anderson Cancer Center with a new targeted cancer therapy. William Apodaca of Paradise Hills received a dose of the radioactive drug Lutathera at Scripps Mercy Hospital San Diego, making him the first patient in the region to receive the new FDA-approved medication.
“This medication is pretty much giving me a second chance at life,” Apodaca told 10 News.
View the segment on 10 News: San Diego patient treated with new targeted cancer therapy
Read the story in The San Diego Union-Tribune: Drug effective against cancer that killed Steve Jobs arrives in San Diego
View the segment on KUSI: Cancer Treatment Milestone at Scripps MD Anderson